Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis

被引:8
|
作者
Mathur, Tarun [1 ]
Kalia, Vandana [1 ]
Barman, Tarani Kanta [1 ]
Singhal, Smita [1 ]
Khan, Seema [1 ,2 ]
Upadhyay, Dilip J. [1 ]
Rattan, Ashok [1 ,3 ]
Raj, V. Samuel [1 ]
机构
[1] Ranbaxy Res Labs, Dept Infect Dis, Gurgaon 122015, India
[2] Netaji Subhash Inst Technol, New Delhi 110078, India
[3] Medanta, Medicity, Gurgaon 122001, Haryana, India
关键词
Anaerobes; Ranbezolid; Linezolid; Metronidazole; Protein synthesis; ANTIMICROBIAL RESISTANCE; OXAZOLIDINONE; AGENTS; INFECTIONS; RBX-7644; ANTIBACTERIAL; ANAEROBES; TRENDS;
D O I
10.1016/j.ijantimicag.2012.09.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study reports the anti-anaerobic properties of ranbezolid, a new investigational oxazolidinone. A time-kill kinetics study against anaerobes showed that ranbezolid was superior to linezolid and killed the anaerobic pathogens at 4-8 h, except for Bacteroides fragilis where killing was observed at 24 h. In addition, the time-kill kinetics study showed a concentration-dependent bactericidal potential of ranbezolid against anaerobes. Ranbezolid showed 5.39 log(10) reduction and linezolid showed 1.15 log(10) reduction in murine disk implant infection with B. fragilis ATCC 25285. Ranbezolid was very potent and showed fast protein synthesis inhibition against B. fragilis, a Gram-negative anaerobe. In addition, non-specific cell wall synthesis inhibition was also observed with ranbezolid. The potent and fast protein synthesis inhibition along with an additional mode of action of cell wall synthesis inhibition could be responsible for the cidal effect of ranbezolid against Gram-negative anaerobes. (C) 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 35 条
  • [1] Evaluation of in vitro activity of a new fluoroquinolone trovafloxacin (cp-99,219) compared with other anti-anaerobic antimicrobials against members of the Bacteroides fragilis group
    Borobio, MV
    Suarez, AI
    Ramirez, E
    Perea, EJ
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1997, 8 (04) : 249 - 252
  • [2] Mode of Action of Ranbezolid against Staphylococci and Structural Modeling Studies of Its Interaction with Ribosomes
    Kalia, Vandana
    Miglani, Rajni
    Purnapatre, Kedar P.
    Mathur, Tarun
    Singhal, Smita
    Khan, Seema
    Voleti, Sreedhara R.
    Upadhyay, Dilip J.
    Saini, Kulvinder Singh
    Rattan, Ashok
    Raj, V. Samuel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1427 - 1433
  • [3] In Vitro Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, Prevotella, Porphyromonas, and Veillonella Species
    Goldstein, Ellie J. C.
    Merriam, C. Vreni
    Citron, Diane M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [4] Enhanced antibacterial activity of uniform and stable chitosan nanoparticles containing metronidazole against anaerobic bacterium of Bacteroides fragilis
    Binesh, Nafiseh
    Farhadian, Nafiseh
    Mohammadzadeh, Alireza
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 202
  • [5] Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria
    Phillips, OA
    Rotimi, VO
    Jamal, WY
    Shahin, M
    Verghese, TL
    JOURNAL OF CHEMOTHERAPY, 2003, 15 (02) : 113 - 117
  • [6] A potential antifungal agent: Insight into the antifungal mechanism against Phomopsis sp
    Yuan, Chunmei
    Zhang, Tao
    Tian, Jiao
    Deng, Tianyu
    Xin, Hui
    Liu, Yi
    Zhang, Yufang
    Xue, Wei
    ARABIAN JOURNAL OF CHEMISTRY, 2024, 17 (01)
  • [7] Gymnema sylvestre as a Potential Anti-Inflammatory and Anti-Biofilm Agent Against Anaerobic Infections: An In Vitro Study
    Miranda, Diego Garcia
    Tome, Fernanda Malagutti
    Miguel, Manuela Maria Viana
    Liberato, Sabrina Ferreira dos Santos
    Marcucci, Maria Cristina
    Vigerelli, Hugo
    Rodrigues, Flavia Pires
    Pacheco-Soares, Cristina
    Godoi, Bruno Henrique
    Carrouel, Florence
    de Oliveira, Luciane Dias
    Ramos, Lucas de Paula
    PLANTS-BASEL, 2025, 14 (04):
  • [8] Anti-candidal activity of a novel peptide derived from human chromogranin A and its mechanism of action against Candida krusei
    Li, Rui-Fang
    Yan, Xiao-Hui
    Lu, Yan-Bo
    Lu, Ya-Li
    Zhang, Hui-Ru
    Chen, Shi-Hua
    Liu, Shuai
    Lu, Zhi-Fang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1768 - 1776
  • [9] In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action
    Xiong, Sheng
    Pang, Hui-dan
    Fan, Jun
    Ge, Feng
    Yang, Xiao-xia
    Liu, Qiu-ying
    Liao, Xiao-jian
    Xu, Shi-hai
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (04) : 909 - 918
  • [10] Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections-A review
    Ahmad, Asif
    Kaleem, Muhammad
    Ahmed, Zaheer
    Shafiq, Hammad
    FOOD RESEARCH INTERNATIONAL, 2015, 77 : 221 - 235